Alex Sapir insider trades

Open-market stock purchases and sales by Alex Sapir, See Remarks at Fulcrum Therapeutics, Inc, from SEC Form 4 filings since Jul 5, 2017.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -67%.

Recent trades

DateStockTradeValue
Feb 2, 2026FULC Fulcrum Therapeutics, IncBought (not open market)—

Companies traded

  • FULC Fulcrum Therapeutics, Inc: 1 buy, last Feb 2, 2026
  • PHAS PhaseBio Pharmaceuticals Inc: other filings, last May 19, 2023
  • DOVA Dova Pharmaceuticals, Inc: 2 buys, last Aug 14, 2018

Get free alerts when Alex Sapir files a new trade →